Prescription Monitoring Program Review Among Patients with Cancer Receiving Opioids at a Safety-Net Palliative Medicine Clinic
A total of 166 patients (20%) were identified as having NMOU behaviors based on clinical review; in contrast, PMP review identified only 31 (4%) patients with NMOU behaviors, and two (6%) were missed by clinical review. Documented PMP concern was low in cancer patients. Clinical review identified most patients with NMOU behaviors, with limited contribution from PMP review. Our findings suggest that PMP should not be used in isolation when assessing opioid-related risk in this population.
Authors
- Soraira Pacheco (ORCID: https://orcid.org/0000-0002-0963-0258)
- Joseph Anthony Arthur (ORCID: https://orcid.org/0000-0002-9185-6108)
- Matthew Manuel (ORCID: https://orcid.org/0000-0002-7560-076X)
- W. Qiao
- Linh M. T. Nguyen
- David Hui
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Cancers
- Published
- 2026-02-27
- DOI
- https://doi.org/10.3390/cancers18050762
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00